Valuation: RaySearch Laboratories AB

Market Cap 7.75B 797M 700M 645M 600M 1.13B 75.9B 1.16B 3B 37.28B 2.99B 2.93B 131B P/E 2026 *
27.2x
P/E 2027 * 21.8x
Enterprise Value 7.66B 788M 692M 638M 593M 1.12B 75.02B 1.14B 2.97B 36.85B 2.96B 2.89B 129B EV / Sales 2026 *
5.43x
EV / Sales 2027 * 4.67x
Free-Float
80.09%
Yield 2026 *
1.77%
Yield 2027 * 2.29%
1 day+2.73%
1 week+9.07%
Current month+2.73%
1 month+2.91%
3 months+18.08%
6 months-0.88%
Current year-0.88%
1 week 201.2
Extreme 201.2
226.8
1 month 200
Extreme 200
227.6
Current year 166.8
Extreme 166.8
237.2
1 year 166.8
Extreme 166.8
373.5
3 years 55.6
Extreme 55.6
373.5
5 years 40
Extreme 40
373.5
10 years 40
Extreme 40
373.5
Manager TitleAgeSince
Chief Executive Officer 57 1999-12-31
Director of Finance/CFO 48 2025-01-26
Chief Tech/Sci/R&D Officer 53 2015-08-27
Director TitleAgeSince
Director/Board Member 57 1999-12-31
Chairman 81 2016-11-17
Chairman 87 2022-09-29
Date Insider Type Main position Quantity % Market Cap.
06-10Buy

Chief Financial Officer

1,386 0.0045%
06-10Buy

General Counsel

1,386 0.0045%
06-10Buy

Executive/Senior Manager

2,310 0.0075%
Change 5-day change 1-year change 3-year change Capi.($)
+2.73%+9.07%-32.54%+257.03% 778M
+3.80%+15.35%-36.03%-6.83% 28.83B
-0.28%+17.31%-28.84%+209.06% 14.7B
+4.67%-10.93% - - 2.53B
-2.19%+6.93% - - 2.16B
+0.99%+9.16%+42.62%-43.08% 1.89B
+1.95%+5.71%-17.56% - 1.33B
+3.75%-3.77%-41.24%-60.38% 730M
+1.89%+32.24%+636.36%+980.00% 727M
+5.90%+19.58%-49.02%-81.06% 610M
Average +2.32%+8.80%+59.22%+179.25% 5.43B
Weighted average by Cap. +2.34%+11.44%-20.73%+74.89%

Financials

2026 *2027 *
Net sales 1.41B 145M 127M 117M 109M 206M 13.8B 210M 546M 6.78B 544M 532M 23.75B 1.6B 165M 145M 133M 124M 235M 15.7B 239M 622M 7.71B 619M 606M 27.02B
Net income 285M 29.31M 25.76M 23.73M 22.08M 41.69M 2.79B 42.55M 111M 1.37B 110M 108M 4.8B 355M 36.51M 32.09M 29.56M 27.5M 51.94M 3.48B 53M 138M 1.71B 137M 134M 5.98B
Net Debt -90M -9.26M -8.13M -7.49M -6.97M -13.17M -882M -13.44M -34.9M -433M -34.76M -34M -1.52B -265M -27.26M -23.95M -22.07M -20.53M -38.77M -2.6B -39.56M -103M -1.28B -102M -100M -4.47B
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
465
Date Price Change Volume
26-07-01 SEK 226.00 +2.73% 130,701
26-06-30 SEK 220.00 +2.23% 214,468
26-06-29 SEK 215.20 +2.57% 329,677
26-06-26 SEK 209.80 +1.84% 176,096
26-06-25 SEK 206.00 +1.28% 70,258
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
226.00SEK
Average target price
330.00SEK
Spread / Average Target
+46.02%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. RAY B Stock